Found 6 matching trials
A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19 PHASE2 This is a randomized, double-blind, placebo-controlled Phase 2 study in par...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2 NA An Investigator-initiated, Randomized, Single-Blind, Placebo-Controlled Tri...
Show More Location
Beijing Ditan Hospital,Capital Medical University
Learn More & Join Trial
HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2 PHASE3 This study will assess the efficacy of HH-120 nasal spray in participants f...
Show More Status
Enrolling By Invitation
Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers PHASE1 This is a clinical study evaluating the safety, tolerability, pharmacokinet...
Show More Location
Beijing TongRen Hospital, Capital Medical University
Learn More & Join Trial
A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19 NA This study is to evaluate the efficacy of post-exposure prevention and safe...
Show More Location
Beijing Ditan Hospital,Capital Medical University
Learn More & Join Trial
A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients NA To evaluate the preliminary efficacy and safety of HH-120 nasal spray in th...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial